http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
姜鎭馨,朴允仲 충남대학교 대학원 원우회 1969 논문집 Vol.2 No.-
(1) This experiment was conducted to investigate the influence on the cork layer formation along the wounds with sharp knife on the cortex of sweet potato tuber. (2) The dosages of X-ray irradiaton were divided into 750r, 1500r, 3000r and the irradiated sweet potato was stored under the two conditions of temp. of 13-15℃ and temp. of 18-20℃. (3) X-ray irradiation hastened to form the cork layer on the wounded cortex of the sweet potato, especially X-ray irradiation of 3000r was superior to the others. (4) X-ray irradiationof 3000r hastened remarkarbly to form the cork layer the above both conditions, compared with the control. (5) X-ray irradiation of 6000r influenced on the formation of the cork layer as strong as that of 3000r, but it made the layer scattered and rough in the latter period. (6) According to above fact, it is considered that X-ray irradiation of about 3000r is able to apply to the hastening of the cork layer formation on the wounded cortex in the sweet potato.
강진형,권정혜,이윤규,박건욱,안호정,손주혁,설영미,이현우,윤환중,안진석,양지현,송헌호,구동회,김진영,김건민,김화정 대한암학회 2020 Cancer Research and Treatment Vol.52 No.3
Purpose The purpose of this study was to compare ramosetron (RAM), aprepitant (APR), and dexamethasone (DEX) [RAD] with palonosetron (PAL), APR, and DEX [PAD] in controlling highlyemetogenic chemotherapy (HEC)–induced nausea and vomiting. Materials and Methods Patients were randomly assigned (1:1) to receive RAD or PAD:RAM (0.3 mg intravenously) or PAL (0.25 mg intravenously) D1, combined with APR (125 mg orally, D1 and 80 mg orally, D2-3) and DEX (12 mg orally or intravenously, D1 and 8 mg orally, D2-4). Patients were stratified by sex, cisplatin-based chemotherapy, and administration schedule. The primary endpoint was overall complete response (CR), defined as no emesis and no rescue regimen during 5 days of HEC. Secondary endpoints were overall complete protection (CP; CR+nausea score < 25 mm) and total control (TC; CR+nausea score < 5 mm). Quality of life was assessed by Functional Living Index Emesis (FLIE) questionnaire on D0 and D6. Results A total of 279 patients receiving RAD (n=137) or PAD (n=142) were evaluated. Overall CR rates in RAD and PAD recipients were 81.8% and 79.6% (risk difference [RD], 2.2%; 95% confidence interval [CI], !7.1 to 11.4), respectively. Overall CP and TC rates for RAD and PAD were 56.2% and 58.5% (RD, !2.3%; 95% CI, !13.9 to 9.4) and 47.5% vs. 43.7% (RD, 3.8%; 95% CI, !7.9 to 15.5), respectively. FLIE total score " 108 (no impact on daily life) was comparable between RAD and PAD (73.9% vs. 73.4%, respectively). Adverse events were similar between the two groups. Conclusion In all aspects of efficacy, safety and quality of life, RAD is non-inferior to PAD for the control of chemotherapy-induced nausea and vomiting in cancer patients receiving HEC.